Single center real-world data on Letermovir prophylaxis for cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation

被引:0
|
作者
Derigs, P. [1 ]
Schubert, M. -L. [1 ]
Schnitzler, P. [2 ]
Mueller-Tidow, C. [1 ]
Dreger, P. [1 ]
Schmitt, M. [1 ]
机构
[1] Heidelberg Univ Hosp, Dept Internal Med 5, Hematol, Oncol,Rheumatol, Heidelberg, Germany
[2] Heidelberg Univ Hosp, Dept Virol, Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V665
引用
收藏
页码:173 / 173
页数:1
相关论文
共 50 条
  • [21] Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study
    Brusosa, Marc
    Ruiz, Sonia
    Monge, Ines
    Solano, Maria Teresa
    Rosinol, Laura
    Esteve, Jordi
    Carreras, Enric
    Marcos, M. Angeles
    Riu, Gisela
    Carcelero, Esther
    Martinez, Carmen
    Fernandez-Aviles, Francesc
    Rovira, Montserrat
    Suarez-Lledo, Maria
    Salas, Maria Queralt
    ANNALS OF HEMATOLOGY, 2024, 103 (02) : 609 - 621
  • [22] Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantation
    Pfeiffer, Thomas
    Lockowitz, Christine R.
    Shenoy, Shalini
    Mavers, Melissa
    Hayashi, Robert
    Bednarski, Jeffrey
    Green, Abby
    BONE MARROW TRANSPLANTATION, 2024, 59 (08) : 1193 - 1195
  • [23] Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection
    Katsuto Takenaka
    Shigeo Fuji
    Toshihiro Matsukawa
    Naoyuki Uchida
    Takeshi Kobayashi
    Masatsugu Tanaka
    Takahide Ara
    Kazuhiro Ikegame
    Yukiyasu Ozawa
    Yoshinobu Kanda
    Masashi Sawa
    Yumiko Maruyama
    Takahiro Fukuda
    Hirohisa Nakamae
    Takafumi Kimura
    Masao Ogata
    Sachiko Seo
    Yoshiko Atsuta
    Keitaro Matsuo
    Hideki Nakasone
    Annals of Hematology, 2024, 103 : 285 - 296
  • [24] Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection
    Takenaka, Katsuto
    Fuji, Shigeo
    Matsukawa, Toshihiro
    Uchida, Naoyuki
    Kobayashi, Takeshi
    Tanaka, Masatsugu
    Ara, Takahide
    Ikegame, Kazuhiro
    Ozawa, Yukiyasu
    Kanda, Yoshinobu
    Sawa, Masashi
    Maruyama, Yumiko
    Fukuda, Takahiro
    Nakamae, Hirohisa
    Kimura, Takafumi
    Ogata, Masao
    Seo, Sachiko
    Atsuta, Yoshiko
    Matsuo, Keitaro
    Nakasone, Hideki
    ANNALS OF HEMATOLOGY, 2023, 103 (1) : 285 - 296
  • [25] Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation
    Takenaka, Katsuto
    Fuji, Shigeo
    Matsukawa, Toshihiro
    Uchida, Naoyuki
    Kobayashi, Takeshi
    Tanaka, Masatsugu
    Ara, Takahide
    Ikegame, Kazuhiro
    Ozawa, Yukiyasu
    Kanda, Yoshinobu
    Sawa, Masashi
    Maruyama, Yumiko
    Fukuda, Takahiro
    Nakamae, Hirohisa
    Kimura, Takafumi
    Ogata, Masao
    Seo, Sachiko
    Atsuta, Yoshiko
    Matsuo, Keitaro
    Nakasone, Hideki
    BLOOD, 2023, 142
  • [26] Letermovir Prophylaxis for Cytomegalovirus Infection in Children After Hematopoietic Cell Transplantation
    RICHERT-PRZYGONSKA, M. O. N. I. K. A.
    JAREMEK, K. A. M. I. L. A.
    DEBSKI, R. O. B. E. R. T.
    KONIECZEK, J. O. A. N. N. A.
    LECKA, M. O. N. I. K. A.
    DZIEDZIC, M. A. G. D. A. L. E. N. A.
    BOGIEL, T. O. M. A. S. Z.
    STYCZYNSKI, J. A. N.
    CZYZEWSKI, K. R. Z. Y. S. Z. T. O. F.
    ANTICANCER RESEARCH, 2022, 42 (07) : 3607 - 3612
  • [27] Prevention of cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation with valganciclovir: Single center experience
    Rzepecki, P.
    Barzal, J.
    Sarosiek, T.
    Oborska, S.
    Szczylik, C.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (01) : 140 - 142
  • [28] LETERMOVIR CYTOMEGALOVIRUS PROPHYLAXIS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Deresinski, Stanley C.
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (03) : I - II
  • [29] Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
    Marty, F. M.
    Ljungman, P.
    Chemaly, R. F.
    Maertens, J.
    Dadwal, S. S.
    Duarte, R. F.
    Haider, S.
    Ullmann, A. J.
    Katayama, Y.
    Brown, J.
    Mullane, K. M.
    Boeckh, M.
    Blumberg, E. A.
    Einsele, H.
    Snydman, D. R.
    Kanda, Y.
    DiNubile, M. J.
    Teal, V. L.
    Wan, H.
    Murata, Y.
    Kartsonis, N. A.
    Leavitt, R. Y.
    Badshah, C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (25): : 2433 - 2444
  • [30] Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
    Chemaly, Roy F.
    Ullmann, Andrew J.
    Stoelben, Susanne
    Richard, Marie Paule
    Bornhaeuser, Martin
    Groth, Christoph
    Einsele, Hermann
    Silverman, Margarida
    Mullane, Kathleen M.
    Brown, Janice
    Nowak, Horst
    Koelling, Katrin
    Stobernack, Hans P.
    Lischka, Peter
    Zimmermann, Holger
    Ruebsamen-Schaeff, Helga
    Champlin, Richard E.
    Ehninger, Gerhard
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19): : 1781 - 1789